WHO Issues New Alert on Falsified Ozempic Batches
Falsified batched of Ozempic have been flagged by the WHO Global Surveillance and Monitoring System for substandard and falsified medicines.
APR Team
New African Nation Reaches WHO Maturity Level 3 In Medicines Regulation
Zimbabwe's National Regulatory Authority has achieved Maturity Level 3 in line with WHO's global benchmarking tool.
GSK raises £1.25 billion from discounted sale of Haleon shares
GSK has sold its remaining 4.2% Haleon shares formalizing its exit from the consumer healthcare division Haleon PLC.
New report highlights pregabalin trafficking as a major concern
The medicine pregabalin is fast becoming an emerging point of concern in the Niger and other parts of West Africa, a UNODC report highlights.
Using AI to tailor drugs for Africa
Nigeria sets pace with rollout of new meningitis vaccine
Nigeria is rolling out the new meningitis vaccine (Men5CV) to fight against a disease that has claimed many lives in the region.
SAHPRA signs MoU with Rwanda Food and Drug Authority
The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Rwanda Food and Drug Authority (Rwanda FDA).
Pfizer Expected To Offload £2 billion Worth Of Haleon Shares
In a strategic move, Pfizer plans to sell 630 million Haleon shares estimated to be worth £2 billion.
The African Pharmaceutical Technology Foundation Receives $12million To Operationalize And Recruit Pharma Expertise
The African Pharmaceutical Technology Foundation will begin its operations in earnest after the African Development Fund provided a grant.
Uganda set to roll out new injectable HIV prevention drug
Uganda will soon be having access to the drug Cabotegravir (CAB-LA). It is hoped that this will fundamentally boost the country’s fight against the scourge of HIV and AIDS. In July 2022, the World Health Organization (WHO) published new guidelines…
